Drug Trial Radar · NCT07894939
Post-Marketing Surveillance to Evaluate the Safety and Effectiveness of Zastaprazan Citrate
Last checked: Nov 20, 2026Latest source record: Oct 26, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
3,000
Planned (sponsor's estimate)
Start
Nov 2, 2024
Primary completion
Dec 31, 2029
Study completion Dec 31, 2029
Sponsor
- Lead sponsor
- Jeil Pharmaceutical Co., Ltd.Industry
- Sponsor type
- Industry
- First posted
- Oct 26, 2026
Design
- Study type
- Observational
- FDA-regulated drug
- No
- Who can join
- All sexes, from 19 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This post-marketing surveillance aims to evaluate the safety and effectiveness of zastaprazan citrate administered in Korean patients receiving the drug in accordance with the approved prescribing information.
Conditions
- Erosive Gastroesophageal Reflux Disease
Interventions
zastaprazan citrateDrug
There is no treatment allocation in this study. Patients who are prescribed zastaprazan citrate at the discretion of their treating physicians will be enrolled consecutively. Zastaprazan citrate will be administered in accordance with the approved prescribing information.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Percentage of Participants With Adverse EventsTime frame: From enrollment to the end of treatment at 8 weeks
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Seoul National University BORAMAE Medical Center
Seoul, South Korea · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.